Quidel Corporation is a medical devices business based in the US. Quidel Corporation shares (QDEL) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $37.48 – a decrease of 3.8% over the previous week. Quidel Corporation employs 7,100 staff and has a trailing 12-month revenue of around $2.8 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $37.48 |
|---|---|
| 52-week range | $29.74 - $75.86 |
| 50-day moving average | $42.17 |
| 200-day moving average | $42.80 |
| Wall St. target price | $51.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-27.03 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $38.58 from 2024-11-19
| 1 week (2024-11-13) | -3.60% |
|---|---|
| 1 month (2024-10-18) | -5.51% |
| 3 months (2024-08-20) | -11.84% |
| 6 months (2024-05-20) | -8.99% |
| 1 year (2023-11-20) | -43.51% |
|---|---|
| 2 years (2022-11-18) | -56.36% |
| 3 years (2021-11-19) | 152.5 |
| 5 years (2019-11-20) | 65.82 |
Valuing Quidel Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Quidel Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Quidel Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.19. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Quidel Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Quidel Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $586.5 million.
The EBITDA is a measure of a Quidel Corporation's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.8 billion |
|---|---|
| Operating margin TTM | 7.12% |
| Gross profit TTM | $1.9 billion |
| Return on assets TTM | 1.04% |
| Return on equity TTM | -45.79% |
| Profit margin | -66.25% |
| Book value | $47.42 |
| Market Capitalization | $2.6 billion |
TTM: trailing 12 months
We're not expecting Quidel Corporation to pay a dividend over the next 12 months.
Over the last 12 months, Quidel Corporation's shares have ranged in value from as little as $29.735 up to $75.855. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Quidel Corporation's is 0.116. This would suggest that Quidel Corporation's shares are less volatile than average (for this exchange).
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use.
Robinhood Launches Presidential Election Event Contracts Ahead of the Nov 5 Presidential Election
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Compare pros, cons, research tools and reviews for these two trading platforms.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
What you need to know about investing in the leading indicator for the overall US stock market.
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.